ACE and Myocardial fibrosis: Using strain imaging in patient follow-up may facilitate the evaluation of infarct size, scarring, myocardial fibrosis, and MACE and allow cardiologists to adjust medications such as antiplatelet therapy (Khan et al., 2016b; Cimmino et al., 2020), angiotensin-converting enzyme inhibitor (ACEI), angiotensin receptor blockers (ARB), angiotensin receptor neprilysin inhibitor (ARNI), β-blockers and SGLT-2i (Paolisso et al., 2022) more precisely.